Department of Medical Biophysics, Schulich School of Medicine and Dentistry, University of Western Ontario, London, ON N6A 5C1, Canada.
Int J Mol Sci. 2021 Jun 18;22(12):6544. doi: 10.3390/ijms22126544.
Cardiovascular diseases (CVDs) are the number one cause of debilitation and mortality worldwide, with a need for cost-effective therapeutics. Autophagy is a highly conserved catabolic recycling pathway triggered by various intra- or extracellular stimuli to play an essential role in development and pathologies, including CVDs. Accordingly, there is great interest in identifying mechanisms that govern autophagic regulation. Autophagic regulation is very complex and multifactorial that includes epigenetic pathways, such as histone modifications to regulate autophagy-related gene expression, decapping-associated mRNA degradation, microRNAs, and long non-coding RNAs; pathways are also known to play roles in CVDs. Molecular understanding of epigenetic-based pathways involved in autophagy and CVDs not only will enhance the understanding of CVDs, but may also provide novel therapeutic targets and biomarkers for CVDs.
心血管疾病(CVDs)是全球导致衰弱和死亡的首要原因,因此需要具有成本效益的治疗方法。自噬是一种高度保守的分解代谢回收途径,由各种细胞内或细胞外刺激触发,在发育和病理学中发挥重要作用,包括 CVDs。因此,人们非常感兴趣的是确定控制自噬调节的机制。自噬调节非常复杂和多因素的,包括表观遗传途径,如组蛋白修饰来调节自噬相关基因的表达、脱帽相关的 mRNA 降解、microRNAs 和长非编码 RNA;这些途径也被认为在 CVDs 中发挥作用。对涉及自噬和 CVDs 的基于表观遗传的途径的分子理解不仅将增强对 CVDs 的理解,而且还可能为 CVDs 提供新的治疗靶点和生物标志物。